DAWN vs UBER · rev $131.2M vs P/E 18, rev $52.02B
Day One Biopharmaceuticals Inc (DAWN) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
DAWN currently screens at market cap $656.8M. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the DAWN and UBER stock pages for the full models.
Not investment advice.